[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371143-105":59,"doc-detail-371143-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","egfl7-inhibits-the-immune-response-in-metastatic-castration-resistant-prostate-cancer-by-deactivating-endothelial-icam-1","EGFL7 Inhibits the Immune Response in Metastatic Castration-Resistant Prostate Cancer by Deactivating Endothelial ICAM-1","","Epidermal growth factor-like 7 (EGFL7) is implicated in multiple cancers, yet its stage-specific role in prostate cancer—especially metastatic castration-resistant prostate cancer (mCRPC)—and its connection to immune regulation remain uncertain. The study measured EGFL7 and intercellular adhesion molecule-1 (ICAM-1) in patient serum and prostate tissues and used siRNA knockdown or overexpression in DU145 and PC3 cells, supported by xenograft and microarray analyses. EGFL7 was elevated in mCRPC and negatively associated with ICAM-1, affecting tumor growth and immune infiltration.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/egfl7-inhibits-the-immune-response-in-metastatic-castration-resistant-prostate-cancer-by-deactivating-endothelial-icam-1/371143/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/egfl7-inhibits-the-immune-response-in-metastatic-castration-resistant-prostate-cancer-by-deactivating-endothelial-icam-1/371143.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of the study on EGFL7 in prostate cancer?","Question",{"text":112,"@type":113},"The study investigated EGFL7’s biological function and its association with immune regulation across prostate cancer stages, focusing on mCRPC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers assess EGFL7 and ICAM-1?",{"text":117,"@type":113},"EGFL7 and ICAM-1 levels were quantified in serum and prostate tissue specimens from patients with BPH, localized PCa, and mCRPC, and EGFL7 was modulated in DU145 and PC3 cells using siRNA or overexpression.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationship did the study find between EGFL7 and ICAM-1?",{"text":121,"@type":113},"ICAM-1 levels were inversely correlated with EGFL7 expression, and EGFL7 knockdown increased ICAM-1 while overexpression reduced it.",{"name":123,"@type":110,"acceptedAnswer":124},"What immune-related effect was linked to EGFL7 in mCRPC?",{"text":125,"@type":113},"EGFL7 silencing inhibited tumor growth and increased CD4/8 lymphocyte infiltration, while EGFL7 overexpression reduced immune evasion markers through downregulating endothelial ICAM-1.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},371143,1790456601,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Original Article  \nProstate cancer  \npISSN: 2287-4208 / eISSN: 2287-4690  \nWorld J Mens Health 2026 Jul 44(3): 702-712  \n[https://doi.org/10.5534/wjmh.250111](https://doi.org/10.5534/wjmh.250111)  \nEGFL7 Inhibits the Immune Response in Metastatic  \nCastration-Resistant Prostate Cancer by Deactivating Endothelial Intercellular Adhesion Molecule-1  \nSeung Soo Lee1,2, Ji Young Lee1, Hyun Jung Lee3, Sung-Woo Park1,2  \n1Department of Urology, Pusan National University School of Medicine, Yangsan, Korea, 2Department of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea, 3Department of Pathology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea  \nPurpose: Epidermal growth factor-like 7 (EGFL7) has been implicated in various cancers, but its role in different stages of prostate cancer (PCa), particularly metastatic castration-resistant prostate cancer (mCRPC), remains unclear. This study aimed to investigate the biological function of EGFL7 and its association with immune regulation in PCa.  \nMaterials and Methods: We quantified EGFL7 and intercellular adhesion molecule-1 (ICAM-1) levels in serum and prostate tissue specimens from patients with benign prostatic hyperplasia (BPH), localized PCa, and mCRPC. To explore its functional role, EGFL7 expression was either silenced or overexpressed in DU145 and PC3 cells using siRNA or pCMV-GFP, respectively. Xenograft experiments were conducted in nude mice using transfected DU145/PC3 cells, followed by post-hoc microarray analysis of tumor tissues.  \nResults: Our findings revealed that EGFL7 expression was significantly higher in both serum and tumor tissues of mCRPC patients compared to those with BPH or localized PCa. ICAM-1 levels were inversely correlated with EGFL7 expression. Knockdown of EGFL7 in DU145 cells suppressed cell proliferation, migration, and invasion, while in vivo studies demonstrated that EGFL7 silencing inhibited tumor growth and increased ICAM-1 expression along with CD4/8 lymphocyte infiltration. Conversely, overexpression of EGFL7 in PC3 cells promoted tumor progression and reduced ICAM-1 levels.  \nConclusions: These findings suggest that EGFL7 overexpression in mCRPC suppresses immune cell infiltration by downregulating endothelial ICAM-1. Our study highlights the potential of EGFL7 as a therapeutic target in advanced PCa.  \nKeywords: Cell adhesion molecules; Endothelium; Epidermal growth factor; Immune evasion; Prostatic neoplasms  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([http://creativecommons.org/licenses/by-nc/4.0)](http://creativecommons.org/licenses/by-nc/4.0))[ ](http://creativecommons.org/licenses/by-nc/4.0))[which permits unrestricted non-commercial use](which permits unrestricted non-commercial use), distribution, and reproduction in any medium, provided the original work is properly cited.  \nINTRODUCTION  \nProstate cancer (PCa) is the second most common malignancy and the fifth leading cause of cancerrelated mortality among men worldwide [1]. While  \nearly-stage PCa can be managed with active surveillance, treatment efforts primarily target advanced and metastatic disease [2,3]. Metastatic castration-resistant prostate cancer (mCRPC), the terminal stage of PCa, is associated with high mortality despite available thera-  \nReceived: Mar 20, 2025 Revised: May 14, 2025 Accepted: Jun 2, 2025 Published online Aug 11, 2025  \nCorrespondence to: Sung-Woo Park  [https://orcid.org/0000-0002-9895-3461](https://orcid.org/0000-0002-9895-3461)  \nDepartment of Urology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, 20 Geumo-ro, Mulgeumeup, Yangsan 50612, Korea.  \nTel: +82-55-360-2672 (2134), Fax: +82-55-360-2164, E-mail: [psw@pusan.ac.kr](psw@pusan.ac.kr)  \n© 2026 Korean Society for Sexual Medicine and Andrology  \npies [4]. The development of effective treatments formCRPC remain","cbCaie2NmQlYEc7B","https://ap.wps.com/l/cbCaie2NmQlYEc7B","pdf",12155591,11,"English","# Purpose\n# Materials and Methods\n## Human sample collection\n## Cell experiments and gene modulation\n## Xenograft and microarray analyses\n# Results\n# Conclusions\n# Keywords","[{\"question\":\"What was the purpose of the study on EGFL7 in prostate cancer?\",\"answer\":\"The study investigated EGFL7’s biological function and its association with immune regulation across prostate cancer stages, focusing on mCRPC.\"},{\"question\":\"How did the researchers assess EGFL7 and ICAM-1?\",\"answer\":\"EGFL7 and ICAM-1 levels were quantified in serum and prostate tissue specimens from patients with BPH, localized PCa, and mCRPC, and EGFL7 was modulated in DU145 and PC3 cells using siRNA or overexpression.\"},{\"question\":\"What relationship did the study find between EGFL7 and ICAM-1?\",\"answer\":\"ICAM-1 levels were inversely correlated with EGFL7 expression, and EGFL7 knockdown increased ICAM-1 while overexpression reduced it.\"},{\"question\":\"What immune-related effect was linked to EGFL7 in mCRPC?\",\"answer\":\"EGFL7 silencing inhibited tumor growth and increased CD4/8 lymphocyte infiltration, while EGFL7 overexpression reduced immune evasion markers through downregulating endothelial ICAM-1.\"}]","EGFL7 Inhibits the Immune Response in Metastatic Castration-Resistant Prostate Cancer by Deactivating Endothelial ICAM-1 | PDF",1790191342,28,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e7768cbdd334ab03387997ab5f08997.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8aa36605613fb4bd6e930eebdcc0136.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee5deebe666414271c33752b884649f9.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/888f97671d84683842fc8a1f61711cb8.webp",980,1306]